Latest / The Light Medicine Podcast / Red Light Therapy and the Brain | The Light Medicine Podcast Ep. 17

Transcript

Red Light Therapy and the Brain | The Light Medicine Podcast Ep. 17 · The Light Medicine Podcast

• 0:00
  SPEAKER_02: Things like ALS, MS, Parkinson's, uh, dementia, Alzheimer's, autism, you know, there there's so many different neurological conditions that essentially, you know, you have infections in the brain, you can have heavy metals, toxicity in the brain, uh triggering inflammation, autoimmune conditions, you know, of the brain or the nerve nervous system.
• 0:23
  SPEAKER_02: So uh to bring in light technology to you know and and what's interesting, what's great with light is that it does so many different things.
• 0:33
  SPEAKER_02: You know, it it turns on mitochondria, it it works especially on the you know, when you look at the red light, you know, really drives that complex four part of the the mitochondria.
• 0:43
  SPEAKER_02: So it really turns that on.
• 0:53
  SPEAKER_05: Let's move the topic a little bit towards the field of regenerative medicine, where we talk about photobiomodulation or low-level laser therapy.
• 1:03
  SPEAKER_05: Maybe in a first step, because we are always throwing out those different terms, you can maybe explain or differentiate the terms of photodynamic therapy on the one hand, what we already talked about, and how it's different to the terms or mechanisms of photobiomodulation or just low-level laser therapy.
• 1:24
  SPEAKER_01: So when we speak about photodynamic treatment, we actually think about destroying something.
• 1:32
  SPEAKER_01: So what we want to do is activate a substance by a certain light wavelength and then uh create uh singlet oxygen species or reactive oxygen species to uh destroy uh really cells or to interact with cells so they went uh so they uh undergo apertouses, for example, their own cell defensive.
• 1:59
  SPEAKER_01: When we talk about photomod biomodulation, what we do is we interact with certain specific systems, mainly in the mitochondria, where to react where we activate certain complexes to have achieved beneficial effects onto and out of the uh pathways which are activated by the mitochondria.
• 2:20
  SPEAKER_01: For example, with red and infrared light, we um activate or upregulate ATP production or nitrum oxide.
• 2:28
  SPEAKER_01: With different other wavelengths, we activate different other complexes in the mitochondria, so we achieve the uh other things.
• 2:34
  SPEAKER_01: Like with green light, we activate the hemoglobin binding sites, so there is a much better efficiency of binding hemoglobin uh or binding oxygen to hemoglobin.
• 2:48
  SPEAKER_01: And this is where so you can determine or you can just uh divide them into a degenerative effect or like a destroying effect, and the photobiomodulation more as a regenerative effect, I would say.
• 3:04
  SPEAKER_01: And this is the main the biggest advantage, and this is what you also have to take in count, is uh many people uh think that uh activation of something is also always beneficial.
• 3:16
  SPEAKER_01: It is when you think about it very specifically.
• 3:19
  SPEAKER_01: Because in photodynamic treatment it's a degenerate effect, so it's not beneficial towards uh regenerating or towards health itself.
• 3:29
  SPEAKER_01: It's a really targeting effect of destroying something, and photobiomodulation is an activable effect towards a very specific system.
• 3:39
  SPEAKER_01: And this is what you have really to um determine or like to separate a bit of.
• 3:45
  SPEAKER_05: Yeah, thank you.
• 3:46
  SPEAKER_05: I think that's very important to differentiate and understand those different terms.
• 3:51
  SPEAKER_05: Um, yeah, as you already said, photobiomodulation or low-level laser therapy is a very effective and yeah, also like a very um yeah promising tool right now in this field of longevity and biohacking.
• 4:05
  SPEAKER_05: Everybody's talking about red light therapy, which is just basically narrowing the field just to red light.
• 4:11
  SPEAKER_05: As we know, we can also use all the different wavelengths of light on a cellular level.
• 4:16
  SPEAKER_05: Um, we have good data showing stem cell activation or uh telomere activation and things like that for having anti-aging effects.
• 4:24
  SPEAKER_05: So PBM is pretty effective in this field, but I think we are always looking for synergies, we are always looking for ways to enhance or improve our protocols.
• 4:34
  SPEAKER_05: And I think good neutraceuticals play a very important role in this part.
• 4:39
  SPEAKER_05: Maybe you can talk a little bit about the synergies of neutraceuticals and light uh light therapies.
• 4:45
  SPEAKER_01: So in the end, we utilize a different uh approach towards the same effect we'd like to have.
• 4:53
  SPEAKER_01: So what will you have with light devices?
• 4:56
  SPEAKER_01: You have a physical effect onto a certain cell with a specific wavelength.
• 5:02
  SPEAKER_01: And by adding neutraceuticals, uh what we have is a pharmacological or pharma kinetic um approach towards the cell types from an agent which is actually creating the same thing.
• 5:17
  SPEAKER_01: So we have a very adding or beneficial effect or synergy between both.
• 5:22
  SPEAKER_01: So it's not the activation of the substance.
• 5:24
  SPEAKER_01: It's actually when we think about Q10, we interact with the mitochondria, we strengthen the mitochondria, and this is what we do by a pharmacological drug substance, and also by the addition of a physical approach to the light device.
• 5:39
  SPEAKER_01: When we think about Glucumin, for example, which is anti-inflammatory, which is directly blocking certain inflammation pathways.
• 5:49
  SPEAKER_01: This is what you can also see by applying blue light, for example.
• 5:53
  SPEAKER_01: So you have a for again a physical effect onto the cell compartment of the cell pathways, and you have a pharmacological effect onto the same pathways, and this is synergizing and very beneficial and even creating much better outcomes than it would be when we would use only one approach on the same thing.
• 6:13
  SPEAKER_05: Yeah, and going back to the wavelengths questions, I think it's important to emphasize again because many people will usually now ask us which wavelengths are you using, why are you using those wavelengths?
• 6:24
  SPEAKER_05: I think it's very important to mention that you have a very special new diet technology now with diets which can emit up to three wavelengths.
• 6:33
  SPEAKER_05: And we are using this combination now of a red wavelength, I think of 680 nanometers, then the very common 810 nanometer um infrared wavelengths, which we were using in all our other devices for many years, of course, um backed up by a lot of research.
• 6:48
  SPEAKER_05: And then what you also already mentioned is the 1064 nanometer infrared wavelengths.
• 6:54
  SPEAKER_05: So, yeah, the rationale behind is to reach different layers of the tissue with different different cellular effects.
• 7:00
  SPEAKER_05: Of course, as I already mentioned, all backed up by a lot of science and research.
• 7:04
  SPEAKER_05: But anyway, we will also talk about this, about the differences of different wavelengths when it comes to penetration, when it comes to cellular effects in one of the next episodes of this podcast where we go into a little bit more into the science behind um this transcranial approach.
• 7:21
  SPEAKER_05: Yeah, I think it's important to mention the different wavelengths we are using, and I think there is no other device or technology on the market right now which is working with um yeah, different wavelengths for different penetration, which have all proven to be very successful in clinical outcomes.
• 7:39
  SPEAKER_03: The um the 808 uh 810 that you mentioned is actually 808.
• 7:43
  SPEAKER_03: Yes, the description is a little bit uh there's an overlap.
• 7:47
  SPEAKER_03: It's uh just make uh make sure.
• 7:50
  SPEAKER_05: Right.
• 7:50
  SPEAKER_05: Yeah.
• 7:51
  SPEAKER_05: And yeah, then for operating the device, you also already mentioned briefly that I think we will have two options by a relatively simple device controller, or you have the option to use a special specially designed app on your phone or tablet where you can basically create your own protocols, target different areas of the brain with different settings, right?
• 8:14
  SPEAKER_03: Correct, and and of course we have to mention that we have two different versions of the of the the headborne design or the system as well.
• 8:22
  SPEAKER_03: So uh we have the home version and the pro version.
• 8:26
  SPEAKER_03: The home version is basically uh how to explain.
• 8:29
  SPEAKER_03: Basically, uh as I mentioned, we have six uh positions on the on the the di on the hex port.
• 8:36
  SPEAKER_03: Six uh diode positions.
• 8:38
  SPEAKER_03: The difference between the home and the pro is basically that's uh in the in the case of the pro, each position has three wavelengths.
• 8:46
  SPEAKER_03: And it's basically three diodes that burst at twenty milliwatt output power each each of them.
• 8:54
  SPEAKER_03: Each position has basically sixty milliwatt output power divided up in these three wavelengths six eighty, eight oh eight, thousand sixty-four.
• 9:03
  SPEAKER_03: In the case of uh the home, these six positions are actually alternated.
• 9:07
  SPEAKER_03: So you would have the opposite sides that have the same uh um wavelength.
• 9:13
  SPEAKER_03: So we have six eighty, and we have eight oh eight, and then we have a thousand sixty-four.
• 9:18
  SPEAKER_03: So basically the difference is that it's uh the the pro is is three times as powerful, so to say.
• 9:26
  SPEAKER_03: Each position has these three these three uh diodes, three wavelengths, first thing at twenty milliwatt each.
• 9:32
  SPEAKER_03: So basically sixty milliwatt.
• 9:34
  SPEAKER_03: In the case of the home, we have twenty milliwatt, twenty twenty twenty, and then we have alternating uh six eighty, eight oh eight, and thousand sixty-four six eighty, eight oh eight, thousand sixty-four.
• 9:46
  SPEAKER_03: So that's the main difference on the device side.
• 9:49
  SPEAKER_03: On the app side, we have a different way of uh controlling it.
• 9:54
  SPEAKER_03: The pro being uh definitely more a professional uh device.
• 9:58
  SPEAKER_03: It's possible to control the different regions on the device that correspond to different regions of the brain.
• 10:04
  SPEAKER_03: Basically, we uh separate this this prototype is not fully fully complete, but we basically uh distinguish uh the frontal side, let's say the back side, the osophotal side, the top side, the parental side, and the temporal side.
• 10:18
  SPEAKER_03: And these sides, these groups, can be separately controlled.
• 10:23
  SPEAKER_03: They can be controlled for output power and frequency.
• 10:26
  SPEAKER_03: And this can be done on the level of each wavelength.
• 10:30
  SPEAKER_03: So doctors can now start very accurately prescribing or composing a certain palette of these three wavelengths at different at different locations and at different output powers and potentially different frequencies even.
• 10:45
  SPEAKER_03: And it is done through a very nice uh user interface.
• 10:48
  SPEAKER_03: We spent a lot of time on this and getting it right.
• 10:51
  SPEAKER_03: Very proud of this uh in the end.
• 10:53
  SPEAKER_03: Um but it gives a tremendous amount of uh of control uh so that certain conditions can be uh treated uh in a different way.
• 11:04
  SPEAKER_03: I've I'm again I'm not a clinician, I have my bachelor in medicine, but uh I don't dare to venture off uh too far in making uh statements uh of therapeutic uh type.
• 11:16
  SPEAKER_03: But I've heard people talking about the value of only using the circular area of the on the brain, and not and not specifically not the parital uh area.
• 11:27
  SPEAKER_03: That could be hugely beneficial.
• 11:29
  SPEAKER_03: And we we offer that control later on, but it will be if there's an ongoing development, we will have even a higher level of control, not so much in the app, because the app has a small user interface.
• 11:40
  SPEAKER_03: But we're looking at uh creating uh a control type of uh setup that gives uh control on the hex level, on the on the small level, and potentially also with a timeline so that you can make patterns changeable.
• 11:55
  SPEAKER_03: So there's again there's different people that are working with uh light therapy that have different theories that are currently actually not possible to implement.
• 12:04
  SPEAKER_03: And um this device and the user interface uh enables uh the clinicians, uh researchers to actually apply these uh different compositions to test their efficacy.
• 12:16
  SPEAKER_05: And just to add, can you tell me how many diets we have in each version in the pro compared to the home version?
• 12:23
  SPEAKER_05: How many laser diets?
• 12:24
  SPEAKER_03: So each hex has six positions.
• 12:30
  SPEAKER_03: In the case of the Pro, each position has three diodes.
• 12:33
  SPEAKER_03: So basically hex has six times three is eighteen uh diodes.
• 12:39
  SPEAKER_03: Times twenty milliwatt, right?
• 12:41
  SPEAKER_03: And the whole system, both for the home and the pro has thirty-eight hexes.
• 12:46
  SPEAKER_03: So we're in the uh around six hundred, what is it, six hundred and eighty-four uh diodes in the pro and two hundred and twenty-eight uh diodes in the home version.
• 12:59
  SPEAKER_03: Yeah, very impressive, as you can all imagine.
• 13:02
  SPEAKER_05: Uh almost seven hundred lasers in div in one device, that's impressive.
• 13:07
  SPEAKER_05: What you already mentioned the beginning a couple of years ago, that would be that would have been impossible due to the high cost of laser technology.
• 13:14
  SPEAKER_05: But nowadays it's possible to create such a device with almost 700 laser diets, so you can all imagine how powerful this device is when it comes to penetration into the brain tissue.
• 13:25
  SPEAKER_05: When we look at the things we are bringing in from our side, which is mainly um the photosynthesizers, which we already talked about, but especially the light technology.
• 13:35
  SPEAKER_05: I think now with the interstitial intravenous light applications, we are already on a good level.
• 13:39
  SPEAKER_05: We can bring good amounts of light energy with different wavelengths deep into the body.
• 13:44
  SPEAKER_05: Where we always had a limitation was of course penetrating into the brain.
• 13:49
  SPEAKER_05: So that's one of the next topics, or basically what we have been working on now for the last two years.
• 13:55
  SPEAKER_05: You know, we are just about to launch our new infrared helmet device for treating all brain-related issues.
• 14:02
  SPEAKER_05: I think you also have quite some experience with that.
• 14:05
  SPEAKER_05: So yeah, how do you rate the potential of um a device like this, which is now really able to bring hundreds or uses hundreds of different laser diets with multiple wavelengths to make sure we achieve a really deep penetration with the light into the brain?
• 14:22
  SPEAKER_02: Yeah, I'm really excited about that because I've I've seen way too many glioblastomas, you know, neurocytomas, astrocytomas, or different types of cancers that metastasize into the brain.
• 14:34
  SPEAKER_02: So being able to bring in a stronger light source to be able to impact, you know, to uh cause a reaction to the photosensitizer we introduce, I think that'd be phenomenal, along with then using uh dietary strategies and also like the polyum VA, DCA, curcumin IV to kind of cause that anti-inflammatory in the brain.
• 14:57
  SPEAKER_02: Or artisinate that also works really well in the brain as well.
• 15:01
  SPEAKER_02: I kind of bring all these strategies together with a stronger light source.
• 15:06
  SPEAKER_02: Yeah, so I'm really excited actually about your about the new helmet that's coming out, using the old version of helmet and and had great uh great results and great effect just with that.
• 15:17
  SPEAKER_02: But this this is just gonna be a game changer.
• 15:19
  SPEAKER_02: So I'm really excited to bring that into my clinic when when it's launched.
• 15:24
  SPEAKER_05: Yeah, that's good to hear.
• 15:25
  SPEAKER_05: And of course, you will be one of the first to get one.
• 15:29
  SPEAKER_05: And I'm of course, or we all are very excited to get first feedback from different clinics, from your clinic, from all over the world.
• 15:37
  SPEAKER_05: Yeah, I also am totally convinced that this will be a um significant game changer, um, not only for treating brain-related cancers, but of course also for neurodegenerative stuff.
• 15:48
  SPEAKER_05: Uh I think you also see some other patients with such issues, right?
• 15:53
  SPEAKER_05: Um now we mainly talked about cancer, but maybe in the end you can also yeah, tell people a little bit more about other things you are doing in regenerative medicine, for example, and how do you incorporate the light in uh those protocols?
• 16:06
  SPEAKER_02: Yeah, yeah, and you're absolutely right.
• 16:08
  SPEAKER_02: We we talked about cancer a lot, but uh my my center we do a lot of other things as well.
• 16:13
  SPEAKER_02: 15,000 square foot facility.
• 16:16
  SPEAKER_02: So we we have a lot of different devices and a lot of different focuses, number of different providers.
• 16:22
  SPEAKER_02: Um so things like ALS, MS, Parkinson's, uh, dementia, Alzheimer's, autism, you know, there's so many different neurological conditions that essentially, you know, you have infections in the brain, you can have heavy metals, toxicity in the brain, uh triggering inflammation, autoimmune conditions, yeah, of the brain or the nerve nervous system.
• 16:46
  SPEAKER_02: So uh to bring in light technology to you know and and what's interesting, what's great with light is that it does so many different things.
• 16:57
  SPEAKER_02: You know, it it turns on mitochondria, it it works especially on the you know, when you look at the red light, you know, it really drives that complex four part of the mitochondria.
• 17:07
  SPEAKER_02: So it really turns that on.
• 17:09
  SPEAKER_02: And then also if you talk about like the fourth phase of water, you know, Dr.
• 17:13
  SPEAKER_02: uh Professor Gerald Polak, you know, where we use light to actually kind of depolarize, you know, the light or uh depolarize water within cells, you know, to create exclusion zone water, easy water, uh, that triggers like a battery effect within the cell, and that in itself also helps to promote energy production.
• 17:37
  SPEAKER_02: And uh and also we know that it upregulates the immune system, it it controls inflammation, you know, does all these different things, and all of that is needed when you deal with neurological conditions.
• 17:50
  SPEAKER_02: And then you can combine that with in addition to using strategies to kill off infections.
• 17:56
  SPEAKER_02: For instance, if you want to do intravenous methylene blue uh and then use the light cap, yeah, we we know methylene blue is very antiviral, yeah, in addition to being a great photosensitizer, in addition to turning on the mitochondria, yeah.
• 18:12
  SPEAKER_02: So you can kind of layer strategies like that.
• 18:15
  SPEAKER_02: Um and then we you can also bring in then regenerative therapies like the uh BPC 157, yeah, yeah, TB500, Times and Alpha 1.
• 18:26
  SPEAKER_02: You you can bring in, depending on what the individual is is dealing with, you can then also bring in different peptides.
• 18:34
  SPEAKER_02: Um there are about 7,000 of them, so there's a lot to choose from to help to regenerate that tissue.
• 18:40
  SPEAKER_02: Then we have exosomes and we have stem cells, and then uh we can bring hyperbaric and we can bring in lipid membrane type of medicine, yeah, like phosphatidylcholine, and and also combining that with some glutathione and some nutrients to help to recycle the glutathione.
• 18:59
  SPEAKER_02: So there's a lot that can be done utilizing this technology and layering that with all these other types of therapies that that we we know and have.
• 19:10
  SPEAKER_05: Yeah, I think that's also one of the beautyful things of light therapy that that it's working in synergy with so many great therapies you are doing, like the injection therapies you were already mentioning, peptide therapies, infusion therapies.
• 19:23
  SPEAKER_05: Everything can be really enhanced by the lasers.
• 19:26
  SPEAKER_05: So yeah, it's not only good in oncology, but in so many different areas of medicine.
• 19:31
  SPEAKER_05: So yeah, thank you for sharing all your experiences in this field.
• 19:35
  SPEAKER_04: I will give a personal story.
• 19:37
  SPEAKER_04: So both my mom and dad have uh severe back issues.
• 19:41
  SPEAKER_04: My father's had two back surgeries.
• 19:43
  SPEAKER_04: He's a doctor, he's a physician himself.
• 19:44
  SPEAKER_04: So he's had two back surgeries, and then most recently he had two strokes.
• 19:48
  SPEAKER_04: He got prostate cancer and kidney cancer.
• 19:49
  SPEAKER_04: Those are treated, but the two strokes were kind of devastating.
• 19:51
  SPEAKER_04: He could not speak properly, he was not able to walk anymore, and he was having, in fact, when he came to my son's wedding, he fell, hit his head, and because he was on blood thinners, he got a huge hematoma and all these things.
• 20:02
  SPEAKER_04: And so so I told him, and so I said, Listen, we're gonna get this photobiomodulation for you, and I'm gonna get some of the other the cranial helmets and these things, and I'm gonna help fix you.
• 20:12
  SPEAKER_04: And uh and I got the RJ laser for my mom.
• 20:14
  SPEAKER_04: So for my mom, I did the RJ laser every morning.
• 20:16
  SPEAKER_04: I wake up, she would say, My back is hurting or my knee is hurting or my hip is hurting, and I would do it for uh 20 minutes of the RJ laser, amazing results.
• 20:24
  SPEAKER_04: She was so happy.
• 20:25
  SPEAKER_04: In fact, she said, Why you didn't buy one for me yet?
• 20:28
  SPEAKER_04: I'm like, Don't worry, mama, as soon as I can I'll get one for you in the US.
• 20:32
  SPEAKER_04: And then so for my dad, because he was having a lot of neurological deterioration, so I said, Okay, we're gonna have to do intravascular and then we're gonna do the helmet.
• 20:39
  SPEAKER_04: And my dad, being a doctor, still he could, you know, he can still comprehend, he just can't speak very well.
• 20:43
  SPEAKER_04: He has an expressive aphasia.
• 20:45
  SPEAKER_04: So he started reading all about photobiomodulation.
• 20:48
  SPEAKER_04: And so um, so every morning uh after I did my mom, then I'd go to my dad's room and then I put the cranial helmet on him, and he would sit patiently, you know, we would usually do a 20-minute or 30-minute session.
• 20:58
  SPEAKER_04: Um, and I can tell you it was a huge, huge difference.
• 21:01
  SPEAKER_04: I mean, huge difference.
• 21:02
  SPEAKER_04: He was able to start speaking uh better words, his expressive aphasia improved, um, his uh joint, so his cerebellar function improved, where uh joint positioning and stuff, so he started walking better.
• 21:13
  SPEAKER_04: Next thing you know, my dad is now going to the swimming pool and doing laps in the swimming pool and walking to the gym every day himself.
• 21:19
  SPEAKER_04: And before we had like my driver had to take him, or somebody had to assist him to get to the he started waking up in the morning, he has his cane, of course, and he would just start tapping on the door or something, and he wants to go to the gym.
• 21:30
  SPEAKER_04: So then he'd go to the gym, and and honestly, uh, I think the health both my parents improved so much with uh this photobiomod.
• 21:37
  SPEAKER_04: And of course, we did a few things, although we did some stem cell injections for him, we did some exosomal injections as well for both of them.
• 21:43
  SPEAKER_04: But really, I think it was the photobiomodulation that probably helped him the most.
• 21:47
  SPEAKER_04: And now you guys have the better version of the helmet, which is amazing.
• 21:51
  SPEAKER_04: The design is amazing, the number of laser diodes you have on it is amazing, and the penetration is amazing.
• 21:56
  SPEAKER_04: And I think this is another for patients with neurodegenerative conditions.
• 22:01
  SPEAKER_04: Anybody who has any kind of Alzheimer's, Parkinson's, frontotemporal dementia, other types of dementias, they should they should get one of these units because uh it is the only it's the only one that's actually going to penetrate the skull.
• 22:11
  SPEAKER_04: I mean, all these red light therapy ones are good.
• 22:14
  SPEAKER_04: And I think the red light therapy ones work because the scalp is highly enervated.
• 22:18
  SPEAKER_04: And so the scalp vessels, and there we know there's communication between the scalp vessels and some of the intracranial vessels.
• 22:24
  SPEAKER_04: In fact, that's why they always tell you, you know, for your face, if you have a pimple, don't pop it.
• 22:28
  SPEAKER_04: And the reason is because the vessels connect to the brain.
• 22:31
  SPEAKER_04: And if you have an infection here, that infection can go in the brain, you can get a you can get a very severe meningo encephalitis.
• 22:37
  SPEAKER_04: And so I think the red light therapies work, but they're they're not very effective, honestly.
• 22:42
  SPEAKER_04: And you need the laser diodes to actually penetrate down, especially if you're going to go into the brain stem or thalamus.
• 22:47
  SPEAKER_04: Those are deep brain structures.
• 22:48
  SPEAKER_04: You will not get any effect from red light therapy.
• 22:50
  SPEAKER_04: You need a proper laser which will uh penetrate safely into that area of the brain.
• 22:54
  SPEAKER_05: Yeah, and you're absolutely right.
• 22:56
  SPEAKER_05: And yeah, you're the brain guy, so I will be or we are all also very excited to get a helmet to you and get your feedback.
• 23:03
  SPEAKER_05: Yes.
• 23:03
  SPEAKER_05: Because I think you will be the one, one of the pioneers in this field when it comes to the research now for transcranial.
• 23:09
  SPEAKER_04: Hopefully, yes.
• 23:10
  SPEAKER_04: I think uh we can uh definitely build on this, and and I'm planning on doing some actual research studies.
• 23:15
  SPEAKER_04: So we actually have patients, we have a number of patients that we're showing, and uh we're showing the differences uh for those patients.